MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Jelfa Pharmaceutical Company

Production, distribution and marketing of solid, semi-solid and injectable preparations.

The company in detail

Summary

Jelfa Pharmaceutical's history dates back to 1945. Soon after the World War II had finished, a group of Polish pioneers, who moved to West Poland, started to operate a small post-German pharmaceutical factory, namely "Labopharma". The first privatisation measures were taken on 2 December 1991 when the firm was transformed into a stock company of the State Treasury; its was also renamed "Polfa" Jelenia Góra. In January of 1994, whilst applying to be listed on the Warsaw Stock Exchange the company changed its name to JELFA Pharmaceutical. The company is focused in the manufacturing of pharmaceuticals for human and veterinary therapy.

Contact details

To view this information, you must subscribe to PL Intelligence.

Head office

Jelfa Pharmaceutical Company
21 Wincentego Pola Str.
Jelenia Góra
58-500
Poland

Related companies

Related categories

Industry sector
Pharmaceutical / Prescription
Pharmaceutical / OTC/Non-Prescription
Pharmaceutical / Generics
Pharmaceutical / Personal Care
Service / Manufacturing
Service / Packaging
Service / Product development
Therapeutic target
Cardiovascular
Cardiovascular / Acute coronary syndromes / Angina
Cardiovascular / Vascular / Hypertension
Central Nervous System / Neurological / Epilepsy
Central Nervous System / Neurodegenerative disorders / Parkinson's disease
Central Nervous System / Psychiatric / Depression
Central Nervous System / Neurodegenerative disorders / Alzheimer's disease
Central Nervous System / Psychiatric / Bipolar disorder
Central Nervous System / Psychiatric / Schizophrenia
Central Nervous System / Neurological / Sleep disorders
Central Nervous System / CNS (other) / Smoking cessation
Dermatological
Dermatological / Acne
Dermatological / Fungal infection
Dermatological / Pruritis
Dermatological / Psoriasis
Dermatological / Alopecia
Endocrinology
Endocrinology / Hormonal disorder (other)
Endocrinology / Hormone replacement therapy
Endocrinology / Menopause
Endocrinology / Testosterone replacement
Endocrinology / Sex hormone (other)
Genito-urinary / Gender related medicine female / Contraception, female
Infectious diseases / Diseases / Infection, fungal (other)
Infectious diseases / Diseases / Infection, viral (other)
Infectious diseases / Diseases / Candidiasis
Infectious diseases / Bacteria or virus / Herpes simplex virus
Infectious diseases / Diseases / Urinary tract infection
Metabolism
Metabolism / Obesity
Metabolism / Mineral supplement
Metabolism / Diabetes type II
Metabolism / Hypercholesterolemia
Musculoskeletal / Musculoskeletal disorder (other)
Musculoskeletal / Skeletal / Rheumatoid arthritis
Musculoskeletal / Skeletal / Osteoporosis

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us